¼¼°èÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2025-2033³â)
Global Cardiac Biomarkers Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
»óǰÄÚµå : 1676215
¸®¼­Ä¡»ç : Value Market Research
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 122 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,920 £Ü 5,671,000
PDF & Excel (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,730 £Ü 6,843,000
PDF & Excel (10-user License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,430 £Ü 10,750,000
PDF & Excel (Corporate User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå ±Ô¸ð´Â 2024³â 45¾ï 5,000¸¸ ´Þ·¯¿¡¼­ 2033³â 226¾ï ´Þ·¯¿¡ ´ÞÇϰí, 2026-2033³âÀÇ ¿¹Ãø ±â°£ µ¿¾È 19.47%ÀÇ °ß°íÇÑ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀº ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, Á¶±â Áø´Ü ¹× °³ÀÎÈ­µÈ Ä¡·á Á¢±Ù¹ý¿¡ ´ëÇÑ Á߿伺 Áõ°¡¿¡ ÈûÀÔ¾î Å« ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üµéÀÌ È¯ÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϱâ À§ÇØ ³ë·ÂÇÔ¿¡ µû¶ó ½ÉÀå ÁúȯÀÇ Áø´Ü°ú °ü¸®¿¡ ÀÖ¾î ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ¿ªÇÒÀÌ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â Æ®·ÎÆ÷´Ñ, ³ªÆ®·ý ÀÌ´¢ ÆéŸÀ̵å, ½ÉÀå °Ç°­ »óÅ¿¡ ´ëÇÑ ±ÍÁßÇÑ ÅëÂû·ÂÀ» Á¦°øÇÏ´Â ±âŸ ´Ü¹éÁúÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ¹ÙÀÌ¿À¸¶Ä¿°¡ Æ÷ÇԵ˴ϴÙ. ½ÉÀå ÁúȯÀÇ À§Çè ¿äÀο¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í Àû½Ã¿¡ °³ÀÔÇØ¾ß ÇÑ´Ù´Â ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ÀÌ ºÎ¹®ÀÇ Ã·´Ü Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

±â¼ú ¹ßÀüÀº ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀÇ ¹ßÀü¿¡ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ÇöÀå °Ë»ç ¹× ½ÇÇè½Ç Áø´ÜÀÇ Çõ½ÅÀº ½ÉÀå Æò°¡ÀÇ ¼Óµµ¿Í Á¤È®¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. °í°¨µµ ºÐ¼® ¹× ´ÙÁß °Ë»ç Ç÷§ÆûÀÇ °³¹ß·Î ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â Á¾ÇÕÀûÀÎ ½ÉÀå ÇÁ·ÎÆÄÀÏÀ» ½Å¼ÓÇÏ°Ô ¾òÀ» ¼ö ÀÖ°Ô µÇ¾î Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ¸ð´ÏÅ͸µ°ú °°Àº µðÁöÅÐ °Ç°­ ±â¼úÀÇ ÅëÇÕÀº ƯÈ÷ ÀÇ·á ¼­ºñ½º¸¦ Á¦´ë·Î ¹ÞÁö ¸øÇÏ´Â »ç¶÷µéÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ½ÃÀåÀÌ ¼º¼÷ÇØÁü¿¡ µû¶ó, Çõ½ÅÀ» ¿ì¼±½ÃÇÏ°í ¿¬±¸°³¹ß¿¡ ÅõÀÚÇÏ´Â ±â¾÷ÀÌ ´Ã¾î³ª´Â ¼ö¿ä¿¡¼­ ´õ Å« Á¡À¯À²À» Â÷ÁöÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

¶ÇÇÑ, ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀº ½ÉÇ÷°ü Ä¡·á¿¡¼­ ¹ÙÀÌ¿À¸¶Ä¿ÀÇ »ç¿ëÀ» ÃËÁøÇÏ´Â ±ÔÁ¦¿Í ÀÓ»ó °¡À̵å¶óÀÎÀÇ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÀÇ·á½Ã½ºÅÛÀÌ ±Ù°ÅÁß½ÉÀÇ Áø·á¹æ½ÄÀ» äÅÃÇÔ¿¡ µû¶ó ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿¸¦ ÀÏ»óÀûÀÎ ÀÓ»ó ¿öÅ©Ç÷ο쿡 ÅëÇÕÇÏ´Â °ÍÀÌ º¸ÆíÈ­µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­´Â »õ·Î¿î ¹ÙÀÌ¿À¸¶Ä¿¸¦ ¹ß°ßÇϰí ÀÓ»óÀû À¯¿ë¼ºÀ» °ËÁõÇϱâ À§ÇÑ ¿¬±¸ ÀÌ´Ï¼ÅÆ¼ºê¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸ÂÃãÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó Ä¡·á ¹æÄ§À» °áÁ¤Çϰí ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿¿¡ ´ëÇÑ ¼ö¿ä´Â ´õ¿í Áõ°¡ÇÒ °ÍÀÔ´Ï´Ù. ÀÓ»óÀû ¿ä±¸¿Í ±ÔÁ¦ ¿ä°Ç¿¡ ºÎÇÕÇÏ´Â Á¦Ç°À» Á¦°øÇÏ´Â ±â¾÷µéÀº ÀÌ ¿ªµ¿ÀûÀÎ ½ÃÀå¿¡¼­ ¼º°øÀ» °ÅµÑ ¼ö ÀÖÀ» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

´ç»çÀÇ º¸°í¼­´Â °í°´¿¡°Ô ´Ù¾çÇÑ »ê¾÷ ¹× ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÌ°í ½Ç¿ëÀûÀÎ ÅëÂû·ÂÀ» Á¦°øÇϱâ À§ÇØ ¼¼½ÉÇÏ°Ô ÀÛ¼ºµÇ¾ú½À´Ï´Ù. °¢ º¸°í¼­¿¡´Â ½ÃÀå »óȲÀ» ¿ÏÀüÈ÷ ÀÌÇØÇϱâ À§ÇÑ ¸î °¡Áö Áß¿äÇÑ ¿ä¼Ò°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä: ½ÃÀå °³¿ä: Á¤ÀÇ, ºÐ·ù, »ê¾÷ ÇöȲÀ» Æ÷ÇÔÇÑ »ó¼¼ÇÑ ½ÃÀå ¼Ò°³.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ: ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× °úÁ¦¸¦ »ó¼¼ÇÏ°Ô ºÐ¼®ÇÕ´Ï´Ù. ÀÌ ¼½¼Ç¿¡¼­´Â ±â¼ú ¹ßÀü, ±ÔÁ¦ º¯È­, »õ·Î¿î Æ®·»µå µîÀÇ ¿äÀÎÀ» °ËÅäÇÕ´Ï´Ù.

¼¼ºÐÈ­ ºÐ¼® : Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ª µîÀÇ ±âÁØ¿¡ µû¶ó ½ÃÀåÀ» ¸íÈ®ÇÑ ºÎ¹®À¸·Î ºÐ·ùÇÕ´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ °¢ ºÎ¹®ÀÇ ¼º°ú¿Í ÀáÀç·ÂÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

°æÀï»óȲ: ½ÃÀå Á¡À¯À², Á¦Ç° Æ÷Æ®Æú¸®¿À, Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê, À繫½ÇÀû µî ÁÖ¿ä ½ÃÀå ÁøÀÔ±â¾÷¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Æò°¡. ÁÖ¿ä ±â¾÷µéÀÌ Ã¤ÅÃÇϰí ÀÖ´Â °æÀï ¿ªÇÐ ¹× ÁÖ¿ä Àü·«¿¡ ´ëÇÑ °íÂûÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

½ÃÀå ¿¹Ãø : °ú°Å µ¥ÀÌÅÍ¿Í ÇöÀç ½ÃÀå »óȲÀ» ¹ÙÅÁÀ¸·Î ÀÏÁ¤ ±â°£ µ¿¾È ½ÃÀå ±Ô¸ð¿Í ¼ºÀå Ãß¼¼¸¦ ¿¹ÃøÇÕ´Ï´Ù. ¿©±â¿¡´Â Á¤·®Àû ºÐ¼®°ú ¹Ì·¡ ½ÃÀå ±ËÀûÀ» ³ªÅ¸³»´Â ±×·¡ÇÁ Ç¥½Ã°¡ Æ÷ÇԵ˴ϴÙ.

Áö¿ª ºÐ¼® : Áö¿ªº° ½ÃÀå ¼º°ú¸¦ Æò°¡Çϰí ÁÖ¿ä ½ÃÀå ¹× Áö¿ª µ¿ÇâÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. Áö¿ª ½ÃÀå ¿ªÇÐ ¹× ºñÁî´Ï½º ±âȸ¸¦ ÀÌÇØÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

»õ·Î¿î Æ®·»µå¿Í ±âȸ: ÇöÀç ½ÃÀå µ¿Çâ°ú »õ·Î¿î ½ÃÀå µ¿Çâ, ±â¼ú Çõ½Å, ÀáÀçÀû ÅõÀÚ ´ë»ó ºÎ¹®À» ½Äº°ÇÕ´Ï´Ù. ¹Ì·¡ ½ÃÀå °³Ã´ ¹× ¼ºÀå Àü¸Á¿¡ ´ëÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ »ê¾÷ ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå ºÐ¼® : À¯Çüº°

Á¦6Àå ¼¼°èÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå ºÐ¼® : ¿ëµµº°

Á¦7Àå ¼¼°èÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå ºÐ¼® : °Ë»ç ºÎÀ§º°

Á¦8Àå ¼¼°èÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦9Àå ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ±â¾÷ °æÀï ±¸µµ

Á¦10Àå ±â¾÷ °³¿ä

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cardiac Biomarkers Market size is anticipated to grow from USD 4.55 Billion in 2024 to USD 22.6 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 19.47% during the forecast period of 2026 to 2033.

The Cardiac Biomarkers market is poised for significant growth, driven by the increasing prevalence of cardiovascular diseases and the growing emphasis on early diagnosis and personalized treatment approaches. As healthcare providers seek to improve patient outcomes, the role of cardiac biomarkers in diagnosing and managing heart conditions has become increasingly critical. This market encompasses a range of biomarkers, including troponins, natriuretic peptides, and other proteins that provide valuable insights into cardiac health. The rising awareness of heart disease risk factors and the need for timely intervention are propelling the demand for advanced diagnostic tools in this sector.

Technological advancements are playing a pivotal role in the evolution of the Cardiac Biomarkers market, with innovations in point-of-care testing and laboratory diagnostics enhancing the speed and accuracy of cardiac assessments. The development of high-sensitivity assays and multiplex testing platforms is enabling healthcare providers to obtain comprehensive cardiac profiles quickly, facilitating informed decision-making. Additionally, the integration of digital health technologies, such as telemedicine and remote monitoring, is expanding access to cardiac biomarker testing, particularly in underserved populations. As the market matures, companies that prioritize innovation and invest in research and development will likely capture a larger share of the growing demand.

Furthermore, the Cardiac Biomarkers market is increasingly influenced by regulatory developments and clinical guidelines that promote the use of biomarkers in cardiovascular care. As healthcare systems adopt evidence-based practices, the incorporation of cardiac biomarkers into routine clinical workflows is becoming more prevalent. This shift is driving investment in research initiatives aimed at discovering novel biomarkers and validating their clinical utility. As the focus on personalized medicine continues to grow, the demand for cardiac biomarkers that can guide treatment decisions and improve patient outcomes will expand. Companies that align their product offerings with clinical needs and regulatory requirements will be well-positioned to thrive in this dynamic market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Type(Myocardial muscle Creatine Kinase (CK-MB), Troponins (T and I), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA), Others, )By Application(Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, Others, )By Location of Testing (Point of care testing, Laboratory testing)

TABLE OF CONTENTS

1. PREFACE

2. EXECUTIVE SUMMARY

3. CARDIAC BIOMARKERS INDUSTRY ANALYSIS

4. VALUE CHAIN ANALYSIS

5. GLOBAL CARDIAC BIOMARKERS MARKET ANALYSIS BY TYPE

6. GLOBAL CARDIAC BIOMARKERS MARKET ANALYSIS BY APPLICATION

7. GLOBAL CARDIAC BIOMARKERS MARKET ANALYSIS BY LOCATION OF TESTING

8. GLOBAL CARDIAC BIOMARKERS MARKET ANALYSIS BY GEOGRAPHY

9. COMPETITIVE LANDSCAPE OF THE CARDIAC BIOMARKERS COMPANIES

10. COMPANY PROFILES OF CARDIAC BIOMARKERS INDUSTRY

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â